BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 10217327)

  • 1. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
    Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
    Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibody recognition of synthetic antigens from MUC1.
    Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
    J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains.
    Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S
    Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structural model of an alpha(2,6)-sialyl-t glycosylated MUC1 eicosapeptide under physiological conditions.
    Dziadek S; Griesinger C; Kunz H; Reinscheid UM
    Chemistry; 2006 Jun; 12(19):4981-93. PubMed ID: 16642533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
    Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
    Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
    Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
    Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
    Matsushita T; Ohyabu N; Fujitani N; Naruchi K; Shimizu H; Hinou H; Nishimura S
    Biochemistry; 2013 Jan; 52(2):402-14. PubMed ID: 23259747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
    Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
    Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.